Lutherville, MD, United States of America

Aleksander S Popel

This inventor holds 15 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Johns Hopkins University, Asclepix Therapeutics, Inc.. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aleksander S Popel. Retrieved from https://idiyas.com/inventor/aleksander-s-popel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 5)

% Patents Active = 86.7

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 91(Granted Patents)

Location History:

Lutherville, MD (US) (2013 - 2021)
Baltimore, MD (US) (2023)
Lutherville-Timonium, MD (US) (2017 - 2024)

Company Filing History:

15 out of 3,798

Johns Hopkins University

patents

1 out of 1

Asclepix Therapeutics, Inc.

patent

where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12527746 - PEPTIDE/PARTICLE DELIVERY SYSTEMS (2026-01-20),

2. 11981754 - Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases (2024-05-14),

3. 11674959 - Methods for identifying and preparing pharmaceutical agents for activating Tie1 and/or Tie2 receptors (2023-06-13),

4. 11155603 - Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases (2021-10-26),

5. 10786463 - Peptide/particle delivery systems (2020-09-29),

6. 10774131 - Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseases (2020-09-15),

7. 10774112 - Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases (2020-09-15),

8. 10106597 - Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseases (2018-10-23),

9. 9802984 - Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases (2017-10-31),

10. 9717694 - Peptide/particle delivery systems (2017-08-01),

11. 9187544 - Peptide modulators of angiogenesis and use thereof (2015-11-17),

12. 9187539 - Compositions having antiangiogenic activity and uses thereof (2015-11-17),

13. 9056923 - Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphagiogenesis-dependent diseases (2015-06-16),

14. 8557772 - Compositions having antiangiogenic activity and uses thereof (2013-10-15),

15. 8507434 - Peptide modulators of angiogenesis and use thereof (2013-08-13),

Title: Inventor Aleksander S Popel - Revolutionizing Biomedical Engineering

Introduction: Aleksander S Popel is a distinguished inventor based in Lutherville, MD, known for his groundbreaking contributions to the field of biomedical engineering.

Latest Patents: Popel's latest patents focus on innovative drug delivery systems, personalized medicine technologies, and advanced medical imaging devices.

Career Highlights: With a career spanning over three decades, Popel has held key positions in various research institutions and universities, where he has spearheaded numerous projects that have led to significant advancements in healthcare technology.

Collaborations: Popel has collaborated with leading pharmaceutical companies, medical device manufacturers, and academic researchers to translate his innovative ideas into real-world applications. His collaborative approach has resulted in several successful products that have improved patient care globally.

Conclusion: In conclusion, Aleksander S Popel's relentless pursuit of innovation in biomedical engineering has cemented his reputation as a visionary inventor whose work continues to have a profound impact on the healthcare industry.

Profile summary based on public USPTO records.